As of May 26
| +0.08 / +0.07%|
The 22 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 120.00, with a high estimate of 150.00 and a low estimate of 86.00. The median estimate represents a +5.03% increase from the last price of 114.25.
The current consensus among 25 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.